Impax Agrees to Settle Flomax Patent Dispute
Impax Laboratories Inc. has reached an agreement with drugmakers Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals Inc. to settle a patent dispute related to a generic version of Flomax, a drug...To view the full article, register now.
Already a subscriber? Click here to view full article